Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

Charles M. Balch; Jeffrey E. Gershenwald; Seng-Jaw Soong; John F. Thompson; Shouluan Ding; David R. Byrd; Natale Cascinelli; Alistair J. Cochran; Daniel G. Coit; Alexander M.M. Eggermont; Timothy M. Johnson; John M. Kirkwood; Stanley P. L. Leong; Kelly M. McMasters; Martín C. Mihm; Donald L. Morton; Merrick I. Ross; Vernon K. Sondak

doi:10.1200/jco.2009.27.1627

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

In this multi-institutional analysis, we demonstrated remarkable heterogeneity of prognosis among patients with stage III melanoma, especially among those with nodal micrometastases. These results should be incorporated into the design and interpretation of future clinical trials involving patients with stage III melanoma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Balch et al. (2010) studied this question.

synapsesocial.com/papers/69dd4f632f737f012599bac5 https://doi.org/10.1200/jco.2009.27.1627

View Full Paper

Ask AI

Bookmark

Share

Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

Ask about this paper

Abstract

Discussion

Cite This Study

Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading